Lotus Asia: CME Sports Betting Contracts & FanDuel’s Unclear Role
Lotus Asia Discusses CME Sports Betting Contracts and FanDuel's Role
- Report suggests CME Group could offer sports event contracts before the end of 2025.
- FanDuel’s role, if any, isn’t yet known.
CME sports betting contracts at Lotus Asia. The CME Group is reportedly preparing to launch sports event contracts, a significant move in the sports betting landscape, but

According to unidentified sources cited by Bloomberg, these sports contracts could be available through futures commission merchants (FCMs) and associated platforms, potentially allowing retail brokers to offer these derivatives to their clients. However, it’s essential to note that details are still fluid and could change as discussions evolve.
This announcement follows closely behind the news that Intercontinental Exchange (NYSE: ICE), which owns the New York Stock Exchange (NYSE), made a $2 billion investment in Polymarket – a top contender in the prediction market space. This investment has valued Polymarket at an impressive $9 billion to $10 billion post-money.
The timing of CME’s possible foray into sports derivatives is revealing, as it coincides with a surge in trading volume within prediction markets during the football season. While some analysts express concern that the reaction to these developments has negatively impacted sports betting stocks, others argue that traditional sportsbooks maintain a significant advantage in terms of handle over prediction markets.
Does FanDuel Fit Into CME Sports Plans?
In August, there was a significant partnership announcement between CME and FanDuel, a subsidiary of Flutter Entertainment (NYSE: FLUT). This partnership aims to offer event contracts tied to significant economic data releases and financial asset prices to sportsbooks clients.
The structure being proposed by CME for these sports contracts appears similar to the existing collaboration with FanDuel. This has sparked speculation on whether the largest online sportsbook could play a role in CME’s sports plans; however, clarity on this remains elusive.
In August, both companies shared their intent to offer yes/no contracts on various daily performances, including major equity indexes like the Nasdaq-100 and S&P 500, alongside commodities, cryptocurrencies, and essential economic data such as GDP and inflation. These derivatives are expected to start as low as $1, with the potential for additional contracts to be offered in the future.
“As we collaborate with CME Group to hone our offerings, we continue to engage with a variety of stakeholders including state regulators, and we have not made any decisions while maintaining an open dialogue in the evolving legal and regulatory landscape,” a representative from FanDuel stated to Bloomberg.
FanDuel Needs to Tread Carefully
The extent of FanDuel’s involvement with CME’s projected sports contracts remains uncertain. Nevertheless, it is evident that the gaming company must proceed cautiously, ideally avoiding any engagement in sports event contracts altogether.
Several states have issued warnings to sportsbook operators indicating that delving into sports event contracts could jeopardise their operating licenses. In a market where the volume for prediction markets is limited compared to traditional sportsbooks, the risk of losing foundational gaming licenses could deter operators from fully investing in this segment.
Key Facts & Considerations
- The CME Group might offer sports contracts by the end of 2025.
- Bloomberg reports that FanDuel’s involvement is still uncertain.
- The sports contract structure could mirror commitments already in place with FanDuel.
- Traditional sportsbook handle is currently much higher than prediction market volumes.
In summary, the direction CME Group takes with its sports contracts could significantly influence the competitive landscape of sports betting, particularly concerning the role of industry giants like FanDuel. Operators will need to carefully navigate regulatory frameworks as they approach this new market.




